Oxidative stress in myopia

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Francisco, Bosch Morell ^a,b   Salvador, Mérida ^a   Amparo, Navea ^a,b  

^a UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

^b FISABIO Oftalmología Médica ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDES; DIAGNOSIS; MEDICAL PROBLEMS; NITRIC OXIDE; OXIDATIVE STRESS; OXYGEN;

ENVIRONMENTAL FACTORS; MOLECULAR MECHANISM; NEUROMODULATION; OXIDATIVE DAMAGE; PEROXYNITRITES; REGULATORY PATHWAY; RETINAL DETACHMENTS; SURGICAL PROCEDURES;

OPHTHALMOLOGY;

DOPAMINE; NITRIC OXIDE; PEROXYNITRITE; SUPEROXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

BLINDNESS; CATARACT; ENVIRONMENTAL FACTOR; GENETICS; GLAUCOMA; HUMAN; MYOPIA; NEUROMODULATION; NONHUMAN; OXIDATIVE STRESS; RETINA DETACHMENT; RETINA MACULA HEMORRHAGE; REVIEW; DRUG EFFECTS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RETINA;

HUMANS; MYOPIA; NITRIC OXIDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RETINA; SUPEROXIDE DISMUTASE;

EID: 84928390887     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/750637     Document Type: Review

References (129)

1. T. Y. Wong, P. J. Foster, J. Hee et al. , "Prevalence and risk factors for refractive errors in adult Chinese in Singapore," Investigative Ophthalmology and Visual Science, vol. 41, no. 9, pp. 2486-2494, 2000.
2. M. R. van Newkirk, "The Hong Kong Vision Study: a pilot assessment of visual impairment in adults," Transactions of the American Ophthalmological Society, vol. 95, pp. 715-749, 1997.
3. E. C. Kim, I. G. Morgan, H. Kakizaki, S. Kang, and D. Jee, "Prevalence and risk factors for refractive errors: Korean NationalHealth andNutrition Examination Survey 2008-2011," PLoS ONE, vol. 8, no. 11, Article ID e80361, 2013.
4. S. Krishnaiah, M. Srinivas, R. C. Khanna, and G. N. Rao, "Prevalence and risk factors for refractive errors in the South Indian adult population: the Andhra Pradesh Eye disease study," Clinical Ophthalmology, vol. 3, no. 1, pp. 17-27, 2009.
5. A. Sawada, A. Tomidokoro, M. Araie, A. Iwase, T. Yamamoto, and Tajimi Study Group, "Refractive errors in an elderly Japanese population: the Tajimi study," Ophthalmology, vol. 115, no. 2, pp. 363-370, 2008.
6. J. H. Kempen, P. Mitchell, K. E. Lee et al. , "The prevalence of refractive errors among adults in the United States, Western Europe, and Australia," Archives of Ophthalmology, vol. 122, no. 4, pp. 495-505, 2004.
7. C. W. Pan, Y. F. Zheng, T. Y. Wong et al. , "Variation inprevalence of myopia between generations of migrant indians living in Singapore," The American Journal of Ophthalmology, vol. 154, no. 2, pp. 376. e1-381. e1, 2012.
8. R. I. Bloom, I. B. Friedman, and R. S. Chuck, "Increasing rates of myopia: the long view," Current Opinion in Ophthalmology, vol. 21, no. 4, pp. 247-248, 2010.
9. I. G. Morgan, K. Ohno-Matsui, and S.-M. Saw, "Myopia," The Lancet, vol. 379, no. 9827, pp. 1739-1748, 2012.
10. S.-M. Saw, G. Gazzard, E. C. Shin-Yen, and W.-H. Chua, "Myopia and associated pathological complications," Ophthalmic and PhysiologicalOptics, vol. 25,no. 5, pp. 381-391, 2005.
11. K. Zadnik, "Its the retina, stupid," Optometry and Vision Science, vol. 78, no. 4, pp. 179-180, 2001.
12. C.-W. Pan, Y.-F. Zheng, A. R. Anuar et al. , "Prevalence of refractive errors in a multiethnic Asian population: the singapore epidemiology of eye disease study," Investigative Ophthalmology and Visual Science, vol. 54, no. 4, pp. 2590-2598, 2013.
13. Y. B. Dayan, A. Levin,Y. Morad et al. , "The changing prevalence of myopia in young adults: a 13-year series of population-based prevalence surveys," Investigative Ophthalmology and Visual Science, vol. 46, no. 8, pp. 2760-2765, 2005.
14. S. Vitale, R. D. Sperduto, and F. L. Ferris III, "Increased prevalence of myopia in the United States between 1971-1972 and 1999-2004," Archives of Ophthalmology, vol. 127, no. 12, pp. 1632-1639, 2009.
15. V. Koh, A. Yang, S. M. Saw et al. , "Differences in prevalence of refractive errors in young Asian males in Singapore between 1996-1997 and 2009-2010,"Ophthalmic Epidemiology, vol. 21,no. 4, pp. 247-255, 2014.
16. B. S. Winkler, M. E. Boulton, J. D. Gottsch, and P. Sternberg, "Oxidative damage and age-related macular degeneration," Molecular Vision, vol. 5, p. 32, 1999.
17. S. Beatty, H.-H. Koh, M. Phil, D. Henson, and M. Boulton, "The role of oxidative stress in the pathogenesis of age-related macular degeneration," Survey of Ophthalmology, vol. 45, no. 2, pp. 115-134, 2000.
18. R. Wojciechowski, "Nature and nurture: the complex genetics of myopia and refractive error," Clinical Genetics, vol. 79, no. 4, pp. 301-320, 2011.
19. H.-J. Lin, L. Wan, Y. Tsai et al. , "Sclera-related gene polymorphisms in highmyopia,"MolecularVision, vol. 15,pp. 1655-1663, 2009.
20. Y. Seko, H. Shimokawa, and T. Tokoro, "Expression of bFGF and TGF-β2 in experimental myopia in chicks," Investigative Ophthalmology and Visual Science, vol. 36, no. 6, pp. 1183-1187, 1995.
21. Z.-H. Deng, J. Tan, S.-Z. Liu, S.-Z. Zhao, and J.-T. Wang, "The correlation between the regulation of recombinant human IGF-2 on eye growth and form-deprivation in guinea pig," Graefes Archive for Clinical and Experimental Ophthalmology, vol. 248, no. 4, pp. 519-525, 2010.
22. T. Wakabayashi, Y. Ikuno, Y. Oshima, T. Hamasaki, and K. Nishida, "Aqueous concentrations of vascular endothelial growth factor in eyes with high myopia with and without choroidal neovascularization," Journal of Ophthalmology, vol. 2013, Article ID 257381, 5 pages, 2013.
23. H.-M. Wu, B. Seet, E. P.-H. Yap, S.-M. Saw, T.-H. Lim, and K.-S. Chia, "Does education explain ethnic differences in myopia prevalence? A population-based study of young adult males in Singapore," Optometry and Vision Science, vol. 78, no. 4, pp. 234-239, 2001.
24. E. B. Dunphy, M. R. Stoll, and S. H. King, "Myopia among american male graduate students," American Journal of Ophthalmology, vol. 65, no. 4, pp. 518-521, 1968.
25. D. O. Mutti, "Hereditary and environmental contributions to emmetropization andmyopia," OptometryandVision Science, vol. 87, no. 4, pp. 255-259, 2010.
26. D. R. Fredrick, "Myopia," British Medical Journal, vol. 324, no. 7347, pp. 1195-1199, 2002.
27. J. Gwiazda, L. Hyman, M. Hussein et al. , "A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children," Investigative Ophthalmology and Visual Science, vol. 44, no. 4, pp. 1492-1500, 2003.
28. L. Deng, J. Gwiazda, R. E. Manny et al. , "Limited change in anisometropia and aniso-axial length over 13 years in myopic children enrolled in the correction of myopia evaluation trial," Investigative Ophthalmology and Visual Science, vol. 55, no. 4, pp. 2097-2105, 2014.
29. T. T. Norton and J. T. Siegwart Jr. , "Animal models of emmetropization: matching axial length to the focal plane," Journal of the American Optometric Association, vol. 66, no. 7, pp. 405-414, 1995.
30. X. Zhu, "Temporal integration of visual signals in lens compensation (a review)," Experimental Eye Research, vol. 114, pp. 69-76, 2013.
31. L. Tong, X. L. Huang, A. L. T. Koh, X. Zhang, D. T. H. Tan, and W.-H. Chua, "Atropine for the treatment of childhoodmyopia: effect on myopia progression after cessation of atropine," Ophthalmology, vol. 116, no. 3, pp. 572-579, 2009.
32. R. M. Siatkowski, S. A. Cotter, R. S. Crockett et al. , "Two-year multicenter, randomized, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia," Journal of AAPOS, vol. 12, no. 4, pp. 332-339, 2008.
33. C. F. Wildsoet, "Neural pathways subserving negative lensinduced emmetropization in chicks-insights from selective lesions of the optic nerve and ciliary nerve," Current Eye Research, vol. 27, no. 6, pp. 371-385, 2003.
34. I. G. Morgan, "The biological basis of myopic refractive error," Clinical and Experimental Optometry, vol. 86, no. 5, pp. 276-288, 2003.
35. G. J. I. Elejalde, "Oxidative stress, diseases and antioxidant treatment," Anales de Medicina Interna, vol. 18, no. 6, pp. 326-335, 2001.
36. A. Izzotti, A. Bagnis, and S. C. Sacca, "The role of oxidative stress in glaucoma," Mutation Research-Reviews in Mutation Research, vol. 612, no. 2, pp. 105-114, 2006.
37. H. Izuta, N. Matsunaga, M. Shimazawa, T. Sugiyama, T. Ikeda, and H. Hara, "Proliferative diabetic retinopathy and relations among antioxidant activity, oxidative stress, and VEGF in the vitreous body," Molecular Vision, vol. 16, pp. 130-136, 2010.
38. W. T. Ham Jr. , H. A. Mueller, J. J. Ruffolo Jr. et al. , "Basicmechanisms underlying the production of photochemical lesions in the mammalian retina," Current Eye Research, vol. 3, no. 1, pp. 165-174, 1984.
39. W. Sickel, "Electrical and metabolic manifestations of receptor and higher-order neuron activity in vertebrate retina," Advances in ExperimentalMedicine and Biology, vol. 24, no. 0, pp. 101-118, 1972.
40. H. Fukui and C. T. Moraes, "The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis?" Trends in Neurosciences, vol. 31, no. 5, pp. 251-256, 2008.
41. B. Frei, R. Stocker, and B. N. Ames, "Antioxidant defenses and lipid peroxidation in human blood plasma," Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 24, pp. 9748-9752, 1988.
42. B. Kisic, D. Miric, L. Zoric, A. Ilic, and I. Dragojevic, "Antioxidant capacity of lenses with age-related cataract," Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 467130, 8 pages, 2012.
43. S. Merida, M. Sancho-Tello, M. Muriach, M. Miranda, A. Navea, and F. Bosch-Morell, "Lipoic acid lessens Th1-mediated inflammation in lipopolysaccharide-induced uveitis reducing selectively Th1 lymphocytes-related cytokines release," Free Radical Research, vol. 47, no. 8, pp. 593-601, 2013.
44. M. L. Chalasani, V. Radha, V. Gupta, N. Agarwal, D. Balasubramanian, and G. Swarup, "A glaucoma-associated mutant of optineurin selectively induces death of retinal ganglion cells which is inhibited by antioxidants," Investigative Ophthalmology andVisual Science, vol. 48, no. 4, pp. 1607-1614, 2007.
45. L. Ye, T. Yu, Y. Li et al. , "Sulforaphane enhances the ability of human retinal pigment epithelial cell against oxidative stress, and its effect on gene expression profile evaluated bymicroarray analysis," Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 413024, 13 pages, 2013.
46. D. R. Crawford, R. J. Lauzon,Y. Wang, J. E. Mazurkiewicz,G. P. Schools, and K. J. A. Davies, "16S mitochondrial ribosomalRNA degradation is associated with apoptosis," Free Radical Biology and Medicine, vol. 22, no. 7, pp. 1295-1300, 1997.
47. L. Bhatt, G. Groeger, K. McDermott, and T. G. Cotter, "Rod and cone photoreceptor cells produce ROS in response to stress in a live retinal explant system,"Molecular Vision, vol. 16, pp. 283-293, 2010.
48. S. Y. Li, Z. J. Fu, and A. C. Y. Lo, "Hypoxia-induced oxidative stress in ischemic retinopathy," OxidativeMedicine and Cellular Longevity, vol. 2012, Article ID 426769, 426769 pages, 2012.
49. E. S. Avetisov and N. F. Savitskaya, "Some features of ocular microcirculation in myopia," Annals of Ophthalmology, vol. 9, no. 10, pp. 1261-1264, 1977.
50. Y.-F. Shih, I.-H. Horng, C.-H. Yang, L. L.-K. Lin, Y. Peng, and P.-T. Hung, "Ocular pulse amplitude in myopia," Journal of Ocular Pharmacology, vol. 7, no. 1, pp. 83-88, 1991.
51. Y.-F. Shih, M. E. C. Fitzgerald, T. T. Norton, P. D. R. Gamlin, W. Hodos, and A. Reiner, "Reduction in choroidal blood flow occurs in chicks wearing goggles that induce eye growth toward myopia," Current Eye Research, vol. 12, no. 3, pp. 219-227, 1993.
52. J. M. McCord, "Superoxide dismutase: rationale for use in reperfusion injury and inflammation," Journal of Free Radicals in Biology and Medicine, vol. 2, no. 5-6, pp. 307-310, 1986.
53. J. Nourooz-Zadeh and P. Pereira, "F2 isoprostanes, potential specific markers of oxidative damage in human retina," Ophthalmic Research, vol. 32, no. 4, pp. 133-137, 2000.
54. F. J. Romero, F. Bosch-Morell, M. J. Romero et al. , "Lipid peroxidation products and antioxidants in human disease," EnvironmentalHealthPerspectives, vol. 106, no. 5,pp. 1229-1234, 1998.
55. A. K. Junk, A. Mammis, S. I. Savitz et al. , "Erythropoietin administration protects retinal neurons from acute ischemiareperfusion injury," Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 16, pp. 10659-10664, 2002.
56. A. Y. Abramov, A. Scorziello, and M. R. Duchen, "Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation," Journal of Neuroscience, vol. 27, no. 5, pp. 1129-1138, 2007.
57. J. M. Rieger, A. R. Shah, and J. M. Gidday, "Ischemiareperfusion injury of retinal endothelium by cyclooxygenaseand xanthine oxidase-derived superoxide," Experimental Eye Research, vol. 74, no. 4, pp. 493-501, 2002.
58. C. E. Berry and J. M. Hare, "Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications," Journal of Physiology, vol. 555, no. 3, pp. 589-606, 2004.
59. J. Matsuo, H. Oku, Y. Kanbara, T. Kobayashi, T. Sugiyama, and T. Ikeda, "Involvement of NADPH oxidase and protein kinase C in endothelin-1-induced superoxide production in retinal microvessels," Experimental Eye Research, vol. 89,no. 5, pp. 693-699, 2009.
60. U. Schonfelder, A. Hofer, M. Paul, and R. H. W. Funk, "In situ observation of living pericytes in rat retinal capillaries," Microvascular Research, vol. 56, no. 1, pp. 22-29, 1998.
61. G. L. Wang, B.-H. Jiang, E. A. Rue, and G. L. Semenza, "Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellularO2 tension," Proceedings of the NationalAcademy of Sciences of theUnited States ofAmerica, vol. 92, no. 12, pp. 5510-5514, 1995.
62. P. A. Campochiaro, "Ocular neovascularization," Journal of Molecular Medicine, vol. 91, no. 3, pp. 311-321, 2013.
63. S. A. Vinores, W.-H. Xiao, S. Aslam et al. , "Implication of the hypoxia response element of the Vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development," Journal of Cellular Physiology, vol. 206, no. 3, pp. 749-758, 2006.
64. R. Lima e Silva, J. Shen, S. F. Hackett et al. , "The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization," The FASEB Journal, vol. 21, no. 12, pp. 3219-3230, 2007.
65. H. Zhang, D. Z. Qian, Y. S. Tan et al. , "Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 50, pp. 19579-19586, 2008.
66. T. Yoshida, H. Zhang, T. Iwase, J. Shen, G. L. Semenza, and P. A. Campochiaro, "Digoxin inhibits retinal ischemia-induced HIF-1α expression and ocular neovascularization," The FASEB Journal, vol. 24, no. 6, pp. 1759-1767, 2010.
67. H. Lu, C. L. Dalgard, A. Mohyeldin, T. McFate, A. S. Tait, and A. Verma, "Reversible inactivation ofHIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1," The Journal of Biological Chemistry, vol. 280, no. 51, pp. 41928-41939, 2005.
68. A. Dong, B. Xie, J. Shen et al. , "Oxidative stress promotes ocular neovascularization," Journal of Cellular Physiology, vol. 219, no. 3, pp. 544-552, 2009.
69. W. G. Kaelin Jr. and P. J. Ratcliffe, "Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway," Molecular Cell, vol. 30, no. 4, pp. 393-402, 2008.
70. A. C. R. Epstein, J. M. Gleadle, L. A. McNeill et al. , "C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation," Cell, vol. 107, no. 1, pp. 43-54, 2001.
71. F. Simonelli, A. Nesti, M. Pensa et al. , "Lipid peroxidation and human cataractogenesis in diabetes and severe myopia," Experimental Eye Research, vol. 49, no. 2, pp. 181-187, 1989.
72. T. Micelli-Ferrari, G. Vendemiale, I. Grattagliano et al. , "Role of lipid peroxidation in the pathogenesis of myopic and senile cataract," British Journal of Ophthalmology, vol. 80, no. 9, pp. 840-843, 1996.
73. E. Altomare, G. Vendemiale, I. Grattagliano, P. Angelini, T. Micelli-Ferrari, and L. Cardia, "Human diabetic cataract: role of lipid peroxidation," Diabete et Metabolisme, vol. 21, no. 3, pp. 173-179, 1995.
74. R. P. Bhatia, R. Rai, and G. R. K. Rao, "Role ofmalondialdehyde and superoxide dismutase in cataractogenesis," Annals of Ophthalmology, vol. 38, no. 2, pp. 103-106, 2006.
75. F. Bosch-Morell, A. Sanz, M. Diaz-Llopis, and F. J. Romero, "Lipid peroxidation products in human subretinal fluid," Free Radical Biology and Medicine, vol. 20, no. 7, pp. 899-903, 1996.
76. J. D. McNeil, O. W. Wiebkin, W. H. Betts, and L. G. Cleland, "Depolymerisation products of hyaluronic acid after exposure to oxygen-derived free radicals," Annals of the Rheumatic Diseases, vol. 44, no. 11, pp. 780-789, 1985.
77. N. Arimura,Y. Ki-I, T. Hashiguchi et al. , "Intraocular expression and release of high-mobility group box 1 protein in retinal detachment," Laboratory Investigation, vol. 89, no. 3, pp. 278-289, 2009.
78. V. Zanon-Moreno, P. Marco-Ventura, A. Lleo-Perez et al. , "Oxidative stress in primary open-angle glaucoma," Journal of Glaucoma, vol. 17, no. 4, pp. 263-268, 2008.
79. G. V. Shkrebets, "Biochemical parameters and prediction of the development of glaucoma in patients with progressive myopia," Vestnik Oftalmologii, vol. 126, no. 5, pp. 17-19, 2010.
80. S. R. Powell, "The antioxidant properties of zinc," Journal of Nutrition, vol. 130, no. 5, pp. 1447S-1454S, 2000.
81. R. D. Jager, W. F. Mieler, and J. W. Miller, "Age-related macular degeneration," The New England Journal of Medicine, vol. 358, no. 24, pp. 2544-2617, 2008.
82. X. Huibi, H. Kaixun, G. Qiuhua, Z. Yushan, and H. Xiuxian, "Prevention of axial elongation in myopia by the trace element zinc," Biological Trace Element Research, vol. 79, no. 1, pp. 39-47, 2001.
83. M. I. Vinetskaia and E. N. Iomdina, "Study of lacrimal fluid trace elements in several eye diseases," Vestnik oftalmologii, vol. 110, no. 4, pp. 24-26, 1994.
84. H. Xu, K. Huang, Q. Gao, Z. Gao, and X. Han, "A study on the prevention and treatment of myopia with nacre on chicks," Pharmacological Research, vol. 44, no. 1, pp. 1-6, 2001.
85. B. Z. Silverstone, N. Syrkin, N. Algur, and D. Berson, "A metabolic aspect of highmyopia," Annals ofOphthalmology, vol. 17, no. 9, pp. 546-551, 1985.
86. B. Z. Silverstone, M. H. Seelenfreund, D. Berson et al. , "Copper and zinc metabolism in high myopic patients with retinal detachment evaluation of the Cu/Zn ratio,"Metabolic, Pediatric, and Systemic Ophthalmology, vol. 9, no. 1, pp. 581-583, 1986.
87. Y. Shi, Y. Li, D. Zhang et al. , "Exome sequencing identifies ZNF644 mutations in high myopia," PLoS Genetics, vol. 7, no. 6, Article ID e1002084, 2011.
88. K.-N. Tran-Viet, E. S. Germain, V. Soler et al. , "Study of a US cohort supports the role of ZNF644 and high-grade myopia susceptibility," Molecular Vision, vol. 18, pp. 937-944, 2012.
89. E. Jamieson and D. Lester, "The novel human p. I587V variant in the ZNF644 gene is unlikely to be the pathogenic cause of dominantly inherited high myopia in a Chinese patient," Investigative Ophthalmology and Visual Science, vol. 53, no. 10, p. 6728, 2012.
90. X. Xiang, T. Wang, P. Tong et al. , "New ZNF644 mutations identified in patients with high myopia," Molecular Vision, vol. 20, pp. 939-946, 2014.
91. L. S. Einbond, K. A. Reynertson, X.-D. Luo, M. J. Basile, and E. J. Kennelly, "Anthocyanin antioxidants fromedible fruits," Food Chemistry, vol. 84, no. 1, pp. 23-28, 2004.
92. K. Kamiya, H. Kobashi, K. Fujiwara,W. Ando, and K. Shimizu, "Effect of fermented bilberry extracts on visual outcomes in eyes with myopia: a prospective, randomized, placebo-controlled study," Journal of Ocular Pharmacology and Therapeutics, vol. 29, no. 3, pp. 356-359, 2013.
93. J. Lee, H. K. Lee, C. Y. Kim et al. , "Purified high-dose anthocyanoside oligomer administration improves nocturnal vision and clinical symptoms in myopia subjects," British Journal of Nutrition, vol. 93, no. 6, pp. 895-899, 2005.
94. I. M. Goldstein, P. Ostwald, and S. Roth, "Nitric oxide: a review of its role in retinal function and disease," Vision Research, vol. 36, no. 18, pp. 2979-2994, 1996.
95. D. Modun, D. Giustarini, and D. Tsikas, "Nitric oxide-related oxidative stress and redox status in health and disease," Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 129651, 3 pages, 2014.
96. G. C. Y. Chiou, "Review: effects of nitric oxide on eye diseases and their treatment," Journal of Ocular Pharmacology and Therapeutics, vol. 17, no. 2, pp. 189-198, 2001.
97. T. Fujikado, Y. Kawasaki, J. Fujii et al. , "The effect of nitric oxide synthase inhibitor on form-deprivation myopia," Current Eye Research, vol. 16, no. 10, pp. 992-996, 1997.
98. T. Fujikado, K. Tsujikawa,M. Tamura, J. Hosohata, Y. Kawasaki, and Y. Tano, "Effect of a nitric oxide synthase inhibitor on lensinducedmyopia," Ophthalmic Research, vol. 33, no. 2, pp. 75-79, 2001.
99. D. L. Nickla, E. Wilken, G. Lytle, S. Yom, and J. Mertz, "Inhibiting the transient choroidal thickening response using the nitric oxide synthase inhibitor l-NAME prevents the ameliorative effects of visual experience on ocular growth in two different visual paradigms," Experimental Eye Research, vol. 83, no. 2, pp. 456-464, 2006.
100. F. Fang, M. Pan, T. Yan et al. , "The role of cGMP in ocular growth and the development of form-deprivation myopia in guinea pigs," Investigative Ophthalmology and Visual Science, vol. 54, no. 13, pp. 7887-7902, 2013.
101. E. Kosenko, M. Llansola, C. Montoliu et al. , "Glutamine synthetase activity and glutamine content in brain: Modulation by NMDA receptors and nitric oxide," Neurochemistry International, vol. 43, no. 4-5, pp. 493-499, 2003.
102. S. Fujii, S. Honda, Y. Sekiya, M. Yamasaki, M. Yamamoto, and K. Saijoh, "Differential expression of nitric oxide synthase isoforms in form-deprived chick eyes," Current Eye Research, vol. 17, no. 6, pp. 586-593, 1998.
103. D. L. Nickla, P. Damyanova, and G. Lytle, "Inhibiting the neuronal isoform of nitric oxide synthase has similar effects on the compensatory choroidal and axial responses to myopic defocus in chicks as does the non-specific inhibitor l-NAME," Experimental Eye Research, vol. 88, no. 6, pp. 1092-1099, 2009.
104. A. W. Siu, G. G. Ortiz, G. Benitez-King,C. H. To, and R. J. Reiter, "Effects of melatonin on the nitric oxide treated retina," British Journal of Ophthalmology, vol. 88, no. 8, pp. 1078-1081, 2004.
105. H. Rios, J. J. Lopez-Costa, N. S. Fosser, A. Brusco, and J. P. Saavedra, "Development of nitric oxide neurons in the chick embryo retina," Developmental Brain Research, vol. 120, no. 1, pp. 17-25, 2000.
106. M. Feldkaemper and F. Schaeffel, "An updated view on the role of dopamine inmyopia," Experimental Eye Research, vol. 114, pp. 106-119, 2013.
107. M. Nebbioso, A. M. Plateroti, B. Pucci, and N. Pescosolido, "Role of the dopaminergic systemin the development ofmyopia in children and adolescents," Journal of Child Neurology, vol. 29, no. 12, pp. 1739-1746, 2014.
108. M. Teves, Q. Shi, W. K. Stell, and D. Eng, "The role of cellcell coupling in myopia development and light adaptation," Investigative Ophthalmology and Visual Science, vol. 55, no. 5, p. 3036, 2014.
109. D. L. Nickla, L. Lee, and K. Totonelly, "Nitric oxide synthase inhibitors prevent the growth-inhibiting effects of quinpirole," Optometry and Vision Science, vol. 90,no. 11, pp. 1167-1175, 2013.
110. R. A. Stone, T. Lin, A. M. Laties, and P. M. Iuvone, "Retinal dopamine and form-deprivation myopia," Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 2, pp. 704-706, 1989.
111. B. L. D. S. Andrade da Costa and J. N. Hokoc, "Coexistence of GAD-65 and GAD-67 with tyrosine hydroxylase and nitric oxide synthase in amacrine and interplexiform cells of the primate, Cebus apella," Visual Neuroscience, vol. 20, no. 2, pp. 153-163, 2003.
112. S. A. Bloomfield and B. Volgyi, "The diverse functional roles and regulation of neuronal gap junctions in the retina," Nature Reviews Neuroscience, vol. 10, no. 7, pp. 495-506, 2009.
113. J. Ara, S. Przedborski, A. B. Naini et al. , "Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)," Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 13, pp. 7659-7663, 1998.
114. U. Landmesser, S. Dikalov, S. R. Price et al. , "Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension," The Journal of Clinical Investigation, vol. 111, no. 8, pp. 1201-1209, 2003.
115. T. Shang, S. Kotamraju, S. V. Kalivendi, C. J. Hillard, and B. Kalyanaraman, "1-Methyl-4-phenylpyridinium-induced apoptosis in cerebellar granule neurons is mediated by transferrin receptor iron-dependent depletion of tetrahydrobiopterin and neuronal nitric-oxide synthase-derived superoxide," The Journal of Biological Chemistry, vol. 279, no. 18, pp. 19099-19112, 2004.
116. R. Heller, A. Unbehaun, B. Schellenberg, B. Mayer, G. Werner-Felmayer, and E. R. Werner, "L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin," The Journal of Biological Chemistry, vol. 276, no. 1, pp. 40-47, 2001.
117. S. P. Ayalasomayajula and U. B. Kompella, "Induction of vascular endothelial growth factor by 4-hydroxynonenal and its prevention by glutathione precursors in retinal pigment epithelial cells,"European Journal of Pharmacology, vol. 449, no. 3, pp. 213-220, 2002.
118. M. Hollborn, K. Jahn, G. A. Limb, L. Kohen, P. Wiedemann, and A. Bringmann, "Characterization of the basic fibroblast growth factor-evoked proliferation of the human Muller cell line, MIO-M1," Graefes Archive for Clinical and Experimental Ophthalmology, vol. 242, no. 5, pp. 414-422, 2004.
119. S. Machida, M. Tanaka, T. Ishii, K. Ohtaka, T. Takahashi, and Y. Tazawa, "Neuroprotective effect of hepatocyte growth factor against photoreceptor degeneration in rats," Investigative Ophthalmology and Visual Science, vol. 45, no. 11, pp. 4174-4182, 2004.
120. L. Tonges, T. Ostendorf, F. Lamballe et al. , "Hepatocyte growth factor protects retinal ganglion cells by increasing neuronal survival and axonal regeneration in vitro and in vivo," Journal of Neurochemistry, vol. 117, no. 5, pp. 892-903, 2011.
121. B. Vasir, P. Reitz, G. Xu, A. Sharma, S. Bonner-Weir, and G. C. Weir, "Effects of diabetes and hypoxia on gene markers of angiogenesis (HGF, cMET, uPA and uPAR, TGF-α, TGF-β, bFGF and Vimentin) in cultured and transplanted rat islets," Diabetologia, vol. 43, no. 6, pp. 763-772, 2000.
122. A. C. Clermont, M. Cahill, H. Salti et al. , "Hepatocyte growth factor induces retinal vascular permeability via MAP-kinase and PI-3 kinase without altering retinal hemodynamics," Investigative Ophthalmology and Visual Science, vol. 47, no. 6, pp. 2701-2708, 2006.
123. K. Makondo,K. Kimura,N. Kitamura et al. , "Hepatocyte growth factor activates endothelial nitric oxide synthase by Ca2+-and phosphoinositide 3-kinase/Akt-dependent phosphorylation in aortic endothelial cells," Biochemical Journal, vol. 374, no. 1, pp. 63-69, 2003.
124. A. Uruno, A. Sugawara,H. Kanatsuka et al. , "Hepatocyte growth factor stimulates nitric oxide production through endothelial nitric oxide synthase activation by the phosphoinositide 3-kinase/Akt pathway and possibly by mitogen-activated protein kinase kinase in vascular endothelial cells," Hypertension Research, vol. 27, no. 11, pp. 887-895, 2004.
125. C. C. Khor, Q. Fan, L.-K. Goh et al. , "Hepatocyte growth factor and retinal arteriolar diameter in Singapore Chinese," Ophthalmology, vol. 117, no. 5, pp. 939-945, 2010.
126. S. Tsuboi, "Elevation of glutathione level in rat hepatocytes by hepatocyte growth factor via induction of gammaglutamylcysteine synthetase," Journal of Biochemistry, vol. 126, no. 5, pp. 815-820, 1999.
127. M. Jin,Y. Chen, S. He, S. J. Ryan, and D. R. Hinton, "Hepatocyte growth factor and its role in the pathogenesis of retinal detachment," Investigative Ophthalmology andVisual Science, vol. 45,no. 1, pp. 323-329, 2004.
128. R. Kannan, M. Jin, M. A. Gamulescu, and D. R. Hinton, "Ceramide-induced apoptosis: role of catalase and hepatocyte growth factor," Free Radical Biology and Medicine, vol. 37, no. 2, pp. 166-175, 2004.
129. M. Jin, J. Yaung, R. Kannan, S. He, S. J. Ryan, and D. R. Hinton, "Hepatocyte growth factor protects RPE cells from apoptosis induced by glutathione depletion," Investigative Ophthalmology andVisual Science, vol. 46, no. 11, pp. 4311-4319, 2005.